News

A new study led by investigators from Mass General Brigham trialed stereotactic (targeted) brain-directed radiation in 100 ...
During a live event, Neal E. Ready, MD, and participants discussed what factors justify using PD-1 plus CTLA-4 inhibitor and ...
Small cell lung cancer is aggressive and spreads quickly. There are many options for treatment, depending on the type and stage of SCLC.
DATROWAY is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and ...
Small cell lung cancer (SCLC) is one of the most aggressive and lethal solid tumors, accounting for ~15% of the approximately 2.5 million patients diagnosed with lung cancer worldwide each year 1,2.
Poster Board: 356 About Small Cell Lung Cancer and ZL-1310 Small cell lung cancer (SCLC) is one of the most aggressive and lethal solid tumors, accounting for ~15% of the approximately 2.5 million ...
Ivonescimab Plus Chemotherapy Demonstrates Statistically Significant and Clinically Meaningful Improvement in Progression-Free Survival in Patients with EGFR-Mutant Non-Small Cell Lung Cancer ...
Presentation Overview: Title: Comparable efficacy and safety of taletrectinib for advanced ROS1+ non–small cell lung cancer across pivotal studies and between races and world regions ...
Revolution Medicines announced promising clinical data for zoldonrasib, a treatment for KRAS G12D mutant non-small cell lung cancer.
Methods We retrospectively reviewed patients with pathologically confirmed non–small cell lung cancer (NSCLC) enrolled in this program at Moi Teaching and Referral Hospital from January 2018 to ...
Cancer is definitely a fatal disease, but if it is identified in the early stages and its treatment is started, then the chances of the patient's survival are very high. Cancer is a life-threatening ...
The facts on small-cell lung cancer, or SCLC, and non-small-cell lung cancer, or NSCLC, like symptoms, prognosis, treatment, and recovery.